Gedea Biotech AB’s Post

Addressing the disparities in women's health has the potential to extend and improve the quality of life for women globally and significantly boost the global economy by an estimated $1 trillion annually by 2040. Yet, the women's health gap continues to be an industry issue. Here are 4 Underlying Causes of the Women's Health Gap 👇 1. Science 🔬: Traditional studies of human biology often focus on the male body, leading to a limited understanding of sex-based biological differences. This results in fewer and less effective treatments specifically designed for women. 2. Data 🔢: The health issues affecting women are frequently underestimated, with many datasets excluding or undervaluing critical conditions that predominantly affect women. 3. Care Delivery 👩⚕️: Women frequently encounter barriers to accessing care, experience delays in diagnosis, and often receive suboptimal treatment compared to men. 4. Investment 💰: There has historically been less investment in health conditions that primarily affect women, perpetuating a cycle of inadequate scientific understanding and insufficient data to support new investments. Together, we can close the health gap by prioritizing research, enhancing data collection, and improving care delivery, leading to better health outcomes and economic growth. https://lnkd.in/gZKa2xZ3 #palomahealth #hypothyroidism #hashimotos #thyroidcare Insights from McKinsey Global Institute

Reducing the women’s health gap improves lives and can potentially unlock a $ 1 trillion GDP opportunity annually by 2040, according to a new analysis from the World Economic Forum in collaboration with the McKinsey Health Institute. Together, they reveal the incredible avenues for creating meaningful global change. Historically, men have led and been the subject of the study of medicine and biology. Most animal models have been done on male specimens, which still prevails today. Questions around sex-based differences were rarely investigated or recorded, with the assumption – now known to be false – that there are few important differences in the functioning of organs and systems in men and women beyond reproduction. This has resulted in ~65% of interventions (which have sex-disaggregated research) being less effective for women than men https://lnkd.in/d6FqexVu

AccendoWave - A Pain #Data Company Women spend 25% more of their lives in debilitating health than men, according to a report from the World Economic Forum and the McKinsey Health Institute. The women's health gap includes a persistent data gap, with women being underdiagnosed for certain conditions compared to men. Here’s what you need to know about the women’s health gap – and six conditions that highlight it. Top 4 Global Health Equity Solution and Top 15 Global Remote Monitoring Company, AccendoWave, benchmarks objective brain wave pain data (specialty, gender, age) and has nine #pain databases: Emergency Department, Maternal Health, Oncology, MSK, Medical Surgical, ICU, #Women, Adults, Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform.

AccendoWave - A Pain #Data Company #Women spend 25% more of their lives in debilitating health than men, according to a report from the World Economic Forum and the McKinsey Health Institute. The women's health gap includes a persistent #data gap, with women being under diagnosed for certain conditions compared to men. A Top 4 Global Health Equity Solution and Top 15 Global Remote Monitoring Company, AccendoWave, benchmarks objective brain wave pain data (specialty, gender, age) and has nine #pain databases: Emergency Department, Maternal Health, Oncology, MSK, Medical Surgical, ICU, #Women, Adults, Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform.

Women are not small men! For a long time I passively assumed that, biologically, our sexual and reproductive organs are the main difference between men and women. That’s wrong. Everything about our biology is different, though science and medicine overwhelmingly treats the sexes as though we the same. This report has raised so many questions for me. How many women in my life & community are not responding well to clinical treatments because the therapies were trialed on, and designed for, male biology? How many might be enduring treatments they don’t need, or are making them worse, because at some point in the care journey their symptoms presented differently than for men? “In some cases, the same condition can have different symptoms or sets of causes; in others, a disease is more prevalent among women. Drugs and medical devices can work differently, too. For example, many drugs to treat rheumatoid arthritis are much less effective on women; ditto for asthma inhalers. Women report adverse events from approved medicines 52% more often than men–and serious ones, including fatalities, 36% more often, according to the FDA. In addition, conditions that disproportionately affect women are systematically underestimated, under-studied, and underinvested in. Only 4% of all healthcare research and development in the U.S. is specifically targeted at women’s health issues.” Read the full piece from McKinsey Health Institute Coleader & Senior Partner Lucy Perez and McKinsey & Company CMO & Senior Partner Tracy Francis in Fortune. #CloseTheWomensHealthGap #WEF24 #globalhealth #womenshealth #mckinseyatdavos

In a recent publication in the Lancet Public Health journal, analysts have highlighted a striking reality: while women tend to outlive men, they also suffer from poorer health throughout their lifetimes. The study underscores the urgent need for measures to address this imbalance and improve the overall health of women globally. #GenderHealthDisparities #WomensHealth #MensHealth #HealthEquity #PublicHealth #MentalHealthAwareness #GlobalHealth #HealthPolicy #GenderEquality #ResearchForChange

💡 Guess what? Women's health issues are underfunded, understudied, and undertreated... But you knew this. We all have... Yet, there's a real opportunity to make changes for the next generation of women, who are starting to navigate women's health issues and will be impacted by mental and physical side effects. I wish all it took was tapping into people's altruism, but that is rarely enough. So, let's skip over the fluff. The gains of "addressing the health gap for women in their 20s alone could add $165 billion to the global economy..." For women like me (and the estimated 190 million others) with endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus, "the market potential for endometriosis treatments is estimated to be worth $180 billion to $220 billion globally." Why? Well, this condition causes severe pelvic pain, infertility, and comorbidities, among other things, and leads to reduced productivity and higher levels of absenteeism. So, imagine the benefits of helping women receive a quicker diagnosis and better treatment. 💰 If our hearts don't push us to achieve health equity, then let it be our wallets. Either way, let it happen. #Women #Health #Endometriosis #HealthEquity

⚡️ News flash! Better health for women is better for everyone. But women spend 25% more time than men in “poor health." Solving that improves the lives of millions of women but also could boost the global economy by at least $1 trillion annually by 2040. Consider some of the following: 👉More than half the health gap for women occurs in working years. 👉Sexual and reproductive health and maternal health account for only some 5% of women’s health burden. 👉An estimated 56% of the burden comes from health conditions that are more prevalent and/or manifest differently in women. 👉Historically, scientific models are mostly based on men and male mice, based on the assumption—now known to be false—that there are few important differences in the functioning of organs and systems in men and women beyond reproduction We've got a long way to go to close the health equity gap. Read the full report from McKinsey in the comments.

While it is not good news that investment in #femtech slid from $2.1B in 2021 to $283M in 2023, there does seem to be increasing support for 2024. (To be fair, all #digitalmedicine funding dropped significantly since 2020, although the percent dedicated to womens health in relation to overall funding is much smaller than in 2020.) There are some encouraging products that address #womenshealth (and not just women only diseases!). I'm looking forward to watching what is emerging. #health #patientcare #digitalhealth #medicaltools #womenandgirlsinscience #womentechsters #womeninvestors https://lnkd.in/eVDcvnrd

It is almost shocking that women’s health is still drastically underfunded. According to a recent McKinsey & Company report, there is a $1 trillion women’s health gap. The report finds that addressing health issues in women in their 20s alone could add a staggering $165 billion to the global economy. The potential market for treating endometriosis, a painful condition affecting potentially 380 million women worldwide, is estimated between $180 billion and $220 billion. Beyond reproductive health, addressing widespread issues like autoimmune diseases and depression, which disproportionately affect women, can significantly improve daily life. Healthcare institutions, governments, investment firms, and employers can play active roles in advancing women's health science, expanding care access, and adjusting workplace policies. The economic benefits are immense, but the true value lies in achieving health equity for women globally. #WomensHealth #HealthEquity #GlobalEconomy #McKinseyReport